Abstract:Background: The induction of CD4(+)CD25(+)Foxp3(+) Treg from CD4(+)CD25(-) T cells is deficient in the patients with systemic lupus erythematosus (SLE). Whether the induced CD4(+)CD25(+)Foxp3(+) Tregs possess defective function remains unclear. The purpose of the present research was to study the expression differences of functional membrane molecule between SLE patients and healthy controls by the induced CD4(+)CD25(+)Foxp3(+) Treg, in order to achieve a better understanding for the function deficiency of Treg in SLE. Methods: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors and SLE patients were used to separated CD4(+)CD25(-) T cells. These CD4(+)CD25(-) T cells were induced to differentiate into CD4(+)CD25(+)Foxp3(+) Tregs through incubating with CD3 and CD28 antibodies, TGF-beta, IL-2 and rapamycin in vitro. Flow cytometry was applied to analyze the expressions of PD-1, PD-L1, CTLA-4, mTGF-beta, LAP, CD39, mIL-10 and cIL-10, by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs. Results: (1) The induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs of both healthy controls and SLE patients both highly expressed PD-1. Nevertheless, the expressions of PD-L1 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were significantly lower than those in healthy controls, which were negatively correlated with SLEDAI; (2) The expressions of CTLA-4 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were also significantly reduced as compared with those in healthy controls, which were negatively correlated with SLEDAI; (3) As compared with healthy controls, the expressions of mTGF-beta by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs were also reduced in SLE patients, but there was no significant difference between active and inactive patients. While the expressions of LAP between SLE patients and healthy controls did not show significant difference; (4) The expressions of CD39 and mIL-10 displayed scarce significant differences between healthy controls and SLE patients, while the expressions of cIL-10 by the induced CD4(+)CD25(+) T cells and the induced CD4(+)CD25(+)Foxp3(+) Tregs in SLE patients were significantly increased, which were not correlated with SLEDAI. Conclusion: There were deficiencies in the expressions of PD-L1 and CTLA-4 in the induced CD4(+)CD25(+)Foxp3(+) Treg of SLE patients, which might be associated with the defective development and function of Treg involved in the pathological process of SLE.

Analysis of Peripheral Blood CD8+ Regulatory Lymphocytes from the Patients with Systemic Lupus Erythematosus

Peripheral CD24hi CD27+ CD19+ B Cells Subset As a Potential Biomarker in Naïve Systemic Lupus Erythematosus.

[Clinical Significance of CD4+CD25+ T Cells in Peripheral Blood of Patients in Systemic Lupus Erythematosus].

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

[Telomerase Activity and Telomere Length in CD4+,CD8+ and CD19+ Lymphocytes from Patients with Systemic Lupus Erythematosus].

Frequency and Significance of CD4+CD25+T Cell Subpopulations in the Peripheral Blood of Patients with Systemic Lupus Erythematosus

Abnormal Expression of Cd43 in Patients with Systemic Lupus Erythematosus and Its Clinical Significance

Progress of the relationship of regulatory T cells and human systemic lupus erythematosus

Aberrant CD200/CD200R1 Expression and Function in Systemic Lupus Erythematosus Contributes to Abnormal T-cell Responsiveness and Dendritic Cell Activity

Peripheral blood T-cell subset and its clinical significance in lupus nephritis patients

Study of T-lymphocyte Activation and Correlation with Disease Activity in Patients with Systemic Lupus Erythematosus

Significance of CD69/CD3 Ratio of Peripheral Blood Mononuclear Cells As a Marker for Evaluating the Disease Activity of Systemic Lupus Erythematosus

Identification and Characterization of CD8+CD27+CXCR3− T Cell Dysregulation and Progression‐Associated Biomarkers in Systemic Lupus Erythematosus

Change and Clinical Significance of Peripheral Blood DN Tregs in Patients with Systemic Lupus Erythematosus

Correlation between levels of dendritic cell subsets in systemic lupus erythematosus patients and SLEDAI

T-lymphocyte subsets (CD3+, CD4+, and CD8+) in Systemic Lupus Erythematosus (SLE): Correlation with Clinical Manifestation

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

[Role of Circulating T Follicular Helper Subsets and T Follicular Helper Effector Memory Cells in Systemic Lupus Erythematosus].

Low expressions of PD-L1 and CTLA-4 by induced CD4<SUP>+</SUP>CD25<SUP>+</SUP> Foxp3<SUP>+</SUP> Tregs in patients with SLE and their correlation with the disease activity

Significance of peripheral blood CD5+B cell in systemic lupus erythematosus